Wird geladen...
Immune checkpoint inhibitor diabetes mellitus: a novel form of autoimmune diabetes
Autoimmune diabetes mellitus is a rare but significant side effect of treatment with immune checkpoint inhibitors. Immune checkpoint inhibitor‐induced diabetes mellitus (CPI‐DM) is characterized by acute onset of dramatic hyperglycemia with severe insulin deficiency and occurrence following exposure...
Gespeichert in:
| Veröffentlicht in: | Clin Exp Immunol |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley and Sons Inc.
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7160652/ https://ncbi.nlm.nih.gov/pubmed/32027018 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cei.13424 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|